» Articles » PMID: 12050007

Polybrene Increases Retrovirus Gene Transfer Efficiency by Enhancing Receptor-independent Virus Adsorption on Target Cell Membranes

Overview
Journal Biophys Chem
Specialty Biochemistry
Date 2002 Jun 7
PMID 12050007
Citations 81
Authors
Affiliations
Soon will be listed here.
Abstract

Cationic polymers, such as polybrene and protamine sulfate, are typically used to increase the efficiency of retrovirus-mediated gene transfer, however, the mechanism of their enhancement of transduction has remained unclear. As retrovirus transduction is fundamentally limited by the slow diffusion of virus to the target cell surface, we investigated the ability of polybrene to modulate this initial transport step. We compared the ability of both envelope (gp70) and capsid (p30) protein based assays to quantitate virus adsorption and found that p30 based assays were more reliable due to their ability to distinguish virus binding from free gp70 binding. Using the p30 based assay, we established that polybrene concentrations, which yielded 10-fold increases in transduction also, yielded a significant increase in virus adsorption rates on murine fibroblasts. Surprisingly, this enhancement, and adsorption in general, were receptor and envelope independent, as adsorption occurred equivalently on receptor positive and negative Chinese hamster ovary cells, as well as with envelope positive and negative virus particles. These findings suggest that the currently accepted physical model for early steps in retrovirus transduction may need to be reformulated to accommodate an initial adsorption step whose driving force does not include the retrovirus concentration, and the reclassification of currently designated 'receptor' molecules as fusion triggers. The implication of these findings with respect to the development of targeted retrovirus-mediated gene therapy protocols is discussed.

Citing Articles

Modeling and correction of protein conformational disease in iPSC-derived neurons through personalized base editing.

Konishi C, Mulaiese N, Butola T, Zhang Q, Kagan D, Yang Q Mol Ther Nucleic Acids. 2025; 36(1):102441.

PMID: 39877004 PMC: 11773622. DOI: 10.1016/j.omtn.2024.102441.


CAR-T cell therapy: developments, challenges and expanded applications from cancer to autoimmunity.

Kong Y, Li J, Zhao X, Wu Y, Chen L Front Immunol. 2025; 15():1519671.

PMID: 39850899 PMC: 11754230. DOI: 10.3389/fimmu.2024.1519671.


EVA1-antibody drug conjugate is a new therapeutic strategy for eliminating glioblastoma-initiating cells.

Hou J, Uejima T, Tanaka M, Son Y, Hanada K, Kukimoto-Niino M Neuro Oncol. 2024; 27(3):682-694.

PMID: 39470407 PMC: 11889714. DOI: 10.1093/neuonc/noae226.


Rapid adaptive evolution of avian leukosis virus subgroup J in response to biotechnologically induced host resistance.

Matouskova M, Plachy J, Kucerova D, Pecnova L, Reinisova M, Geryk J PLoS Pathog. 2024; 20(8):e1012468.

PMID: 39146367 PMC: 11349186. DOI: 10.1371/journal.ppat.1012468.


The Role of Twist1 in Chronic Pancreatitis-Associated Pancreatic Stellate Cells.

Geister E, Ard D, Patel H, Findley A, DeSouza G, Martin L Am J Pathol. 2024; 194(10):1879-1897.

PMID: 39032603 PMC: 11423762. DOI: 10.1016/j.ajpath.2024.06.003.